Reneo Pharmaceuticals, Inc. - Class A Common Stock (RPHM)
1.8200
0.00 (0.00%)
Reneo Pharmaceuticals is a biotechnology company focused on developing innovative therapies for rare mitochondrial diseases and other genetic disorders
The company is dedicated to advancing treatments that target the underlying mechanisms of these conditions to improve patient outcomes and quality of life. Reneo's research efforts are centered on harnessing the potential of small molecule drugs that can enhance mitochondrial function and metabolism, addressing significant unmet medical needs in the field of rare diseases. Through its cutting-edge scientific approach and commitment to patient-centered care, Reneo aims to make a meaningful impact in the lives of individuals affected by these challenging conditions.
Frequently Asked Questions
Is Reneo Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Reneo Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Reneo Pharmaceuticals, Inc. - Class A Common Stock trade on?
Reneo Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Reneo Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Reneo Pharmaceuticals, Inc. - Class A Common Stock is RPHM on the Nasdaq Stock Market
What is the current price of Reneo Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Reneo Pharmaceuticals, Inc. - Class A Common Stock is 1.820
When was Reneo Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Reneo Pharmaceuticals, Inc. - Class A Common Stock was at 4:00 pm EDT on October 4th, 2024